Use of a copolymer dressing on superficial and XXXX in a paediatric population.

@entity1 @entity121 @entity158 @entity2737
OBJECTIVE: Despite extensive research into the treatment of @entity121 , to date there has not been the emergence of a preeminent modality. This pilot study, the first such study to be performed in a burn unit in the US, was designed to evaluate the efficacy and outcomes of the application of copolymer dressing (Suprathel; PolyMedics Innovations Corporation, Stuttgart, Germany) for both superficial and deeper @entity121 . METHOD: The copolymer dressing was used as a primary wound dressing to treat superficial and deep @entity121 (average 5% total body surface area) in paediatric @entity1 . Burns were debrided within 24 hours, at bedside, in the burn unit or in the operating room. The copolymer dressing was then applied directly to the wound and covered with a non-adherent second layer and an absorptive outer dressing. After discharge, @entity1 were seen every 5-7 days until healed. Parameters evaluated included average hospital length of stay, average number of intravenous doses of narcotics administered, @entity158 score at first follow-up visit, average time to complete re epithelialisation, incidence of @entity2737 , and @entity1 /parent satisfaction on a 4-point scale. We also evaluated our experience with the dressing. Data were evaluated retrospectively under an Investigational Review Board approved protocol. RESULTS: Of the 17 @entity1 assessed the average hospital length of stay was 1.4 days during which the average number of intravenous narcotic doses administered before copolymer dressing application was 1.5 and after was 0.1 doses. At the first follow-up visit, average @entity158 score was 1.2 on a 10-point scale and the average time to re epithelialisation was 9.5 days. There was no incidence of @entity2737 . @entity1 /parent satisfaction was average of 3.66 on a 4-point scale. The staff had found that the self-adherence and elasticity of the dressing made it easy to apply and stay adherent, especially in areas of difficult contour. There were no readmissions for further debridement or skin grafting. CONCLUSION: Our experience shows that @entity1 may be discharged shortly after the application of the copolymer dressing, with manageable @entity158 scores and ease of use as determined by the caretakers high satisfaction. This new, fully synthetic copolymer dressing is easy to apply, does not require any additional antimicrobial coverage and may be used to successfully manage deeper @entity121 , donor sites or burns in areas of contour, where many other dressings might not be considered or be appropriate. DECLARATION OF INTEREST: None declared.
